| Name | Title | Contact Details |
|---|---|---|
John Kelly |
Chief Information Officer | Profile |
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.
Radeas is a clinical laboratory that offers testing for toxicology, COVID-19, PGX, UTI, and blood. They provide timely and accurate information to help guide decisions and ensure improved outcomes, with excellent customer service and a broad network of...
Colonial Manors Of Custer is a Custer, SD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Med-El Corporation is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Solace Pediatric Healthcare is a leading provider of pediatric occupational, physical, speech and feeding therapy services in the state of Colorado. They offer in-home and telehealth therapy services for infants and children with developmental delays o...